Previous studies found that the APOE ε4 carriers have greater hippocampal atrophy than the non-carriers in patients with AD, cognitively normal elderly, and healthy young adults (O'Dwyer et al., 2012; Chang et al., 2019; Dong et al., 2019). Here, APOE is linked to Alzheimer disease.